Indeed, our investigation showed that g-MDSCs had a significantly high survival rate, a high level of STAT3 activation, and expressed a large amount of Mpo and Ne (Figure S3) in the NAFLD microenvironment. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatotic liver disease.